330 related articles for article (PubMed ID: 29342970)
21. Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia.
Bartaula-Brevik S; Lindstad Brattås MK; Tvedt THA; Reikvam H; Bruserud Ø
Expert Opin Investig Drugs; 2018 Apr; 27(4):377-387. PubMed ID: 29611449
[TBL] [Abstract][Full Text] [Related]
22. A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia.
De Toni F; Racaud-Sultan C; Chicanne G; Mas VM; Cariven C; Mesange F; Salles JP; Demur C; Allouche M; Payrastre B; Manenti S; Ysebaert L
Oncogene; 2006 May; 25(22):3113-22. PubMed ID: 16407823
[TBL] [Abstract][Full Text] [Related]
23. Vacuolar ATPase as a possible therapeutic target in human acute myeloid leukemia.
Aasebø E; Bartaula-Brevik S; Hernandez-Valladares M; Bruserud Ø
Expert Rev Hematol; 2018 Jan; 11(1):13-24. PubMed ID: 29168399
[TBL] [Abstract][Full Text] [Related]
24. The biological functions of beta3 integrins.
Switala-Jelen K; Dabrowska K; Opolski A; Lipinska L; Nowaczyk M; Gorski A
Folia Biol (Praha); 2004; 50(5):143-52. PubMed ID: 15581065
[TBL] [Abstract][Full Text] [Related]
25. Identification of a HoxA10 activation domain necessary for transcription of the gene encoding beta3 integrin during myeloid differentiation.
Bei L; Lu Y; Bellis SL; Zhou W; Horvath E; Eklund EA
J Biol Chem; 2007 Jun; 282(23):16846-59. PubMed ID: 17439948
[TBL] [Abstract][Full Text] [Related]
26. The translational blocking of α5 and α6 integrin subunits affects migration and invasion, and increases sensitivity to carboplatin of SKOV-3 ovarian cancer cell line.
Villegas-Pineda JC; Toledo-Leyva A; Osorio-Trujillo JC; Hernández-Ramírez VI; Talamás-Rohana P
Exp Cell Res; 2017 Feb; 351(2):127-134. PubMed ID: 28131812
[TBL] [Abstract][Full Text] [Related]
27. Expression of beta 1 integrin mRNAs in human leukemic blasts.
Janiak M; Sawicki G; Janowska-Wieczorek A
Leukemia; 1994 Sep; 8(9):1544-50. PubMed ID: 7522292
[TBL] [Abstract][Full Text] [Related]
28. [Key molecular mechanisms associated with cell malignant transformation in acute myeloid leukemia].
Orlova NN; Lebedev TD; Spirin PV; Prassolov VS
Mol Biol (Mosk); 2016; 50(3):395-405. PubMed ID: 27414778
[TBL] [Abstract][Full Text] [Related]
29. Functional and computational studies of the ligand-associated metal binding site of beta3 integrins.
Murcia M; Jirouskova M; Li J; Coller BS; Filizola M
Proteins; 2008 Jun; 71(4):1779-91. PubMed ID: 18175315
[TBL] [Abstract][Full Text] [Related]
30. Activin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin β3 via SMAD2/3 signaling.
Xiong S; Klausen C; Cheng JC; Zhu H; Leung PC
Oncotarget; 2015 Oct; 6(31):31659-73. PubMed ID: 26384307
[TBL] [Abstract][Full Text] [Related]
31. Tetraspanin CD82 drives acute myeloid leukemia chemoresistance by modulating protein kinase C alpha and β1 integrin activation.
Floren M; Restrepo Cruz S; Termini CM; Marjon KD; Lidke KA; Gillette JM
Oncogene; 2020 May; 39(19):3910-3925. PubMed ID: 32203165
[TBL] [Abstract][Full Text] [Related]
32. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
Xue W; Mizukami I; Todd RF; Petty HR
Cancer Res; 1997 May; 57(9):1682-9. PubMed ID: 9135008
[TBL] [Abstract][Full Text] [Related]
33. Bone mineralization and osteoblast differentiation are negatively modulated by integrin alpha(v)beta3.
Cheng SL; Lai CF; Blystone SD; Avioli LV
J Bone Miner Res; 2001 Feb; 16(2):277-88. PubMed ID: 11204428
[TBL] [Abstract][Full Text] [Related]
34. Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia.
Wang H; Lindsey S; Konieczna I; Bei L; Horvath E; Huang W; Saberwal G; Eklund EA
J Biol Chem; 2009 Jan; 284(4):2549-67. PubMed ID: 19022774
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of c-Myc determines sensitivity to 2-methoxyestradiol-induced apoptosis in human acute myeloid leukemia.
Chow JM; Liu CR; Lin CP; Lee CN; Cheng YC; Lin S; Liu HE
Exp Hematol; 2008 Feb; 36(2):140-8. PubMed ID: 18206725
[TBL] [Abstract][Full Text] [Related]
36. S100 Proteins in Acute Myeloid Leukemia.
Brenner AK; Bruserud Ø
Neoplasia; 2018 Dec; 20(12):1175-1186. PubMed ID: 30366122
[TBL] [Abstract][Full Text] [Related]
37. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic T lymphocytes express a beta3 integrin which can induce the phosphorylation of focal adhesion kinase and the related PYK-2.
Ma EA; Lou O; Berg NN; Ostergaard HL
Eur J Immunol; 1997 Jan; 27(1):329-35. PubMed ID: 9022036
[TBL] [Abstract][Full Text] [Related]
39. Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin.
Han Y; Ye A; Zhang Y; Cai Z; Wang W; Sun L; Jiang S; Wu J; Yu K; Zhang S
PLoS One; 2015; 10(8):e0136484. PubMed ID: 26308531
[TBL] [Abstract][Full Text] [Related]
40. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
